Latest News
-

The brain in Huntington's disease: greater than the sum of its parts?
An important new study asks the question: what parts of the brain might need most help in HD?
-

NUB1: enhancing clearance to decrease mutant huntingtin
NUB1 increases mutant huntingtin removal from cells, reducing the toxic effects of HD in fruit flies
-

Raptor announces results of cysteamine trial for Huntington's disease
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
-

Sleep, cilia and HD
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
-

Huntington's Disease Therapeutics Conference 2014: day 3
Biomarkers and preparing for trials: the third & final day of the 2014 Huntington's Disease Therapeutics Conference
-

Huntington's Disease Therapeutics Conference 2014: day 2
Cells, circuits and systems: day 2 of the 2014 HD Therapeutics conference
-

Huntington's Disease Therapeutics Conference 2014: day 1
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
-

Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?


